Evidence map›Paper›PMID 20363391›Full record

ReviewAnalytica chimica acta2010

Multi-dimensional liquid chromatography in proteomics--a review.

Xiang Zhang, Aiqin Fang, Catherine P Riley, Mu Wang, Fred E Regnier, Charles Buck

Abstract readReview
In one paragraph

Review in Analytica chimica acta, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 39 papers.

0numbers the graph read from it
0cells of the map it votes in
39citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

39 citing papers in PubMed.

  1. Review
  2. Proteomics ofACS omega · 2024
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Effect of NaCl stress on exoproteome profiles ofFrontiers in microbiology · 2023
    Article
  9. The atrial and ventricular myocardial proteome of end-stage lamin heart disease.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2023
    Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Using proteomics as a powerful tool to develop a vaccine against Mediterranean visceral leishmaniasis.Journal of parasitic diseases : official organ of the Indian Society for Parasitology · 2018
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xiang ZhangDepartment of Chemistry, University of Louisville, 2320 South Brook Street, Louisville, KY 40292, USA. xiang.zhang@louisville.edu
Aiqin Fang
Catherine P Riley
Mu Wang
Fred E Regnier
Charles Buck

Funding

APT: the Analytical Proteomics TeamU24CA126480 · NCI · PURDUE UNIVERSITY · PI REGNIER, FRED E · 2006 to 2010
$6.4M
NCI NIH HHS 1U24 CA126480-01NCI NIH HHS U24 CA126480
6 · The paper itself

Abstract

Proteomics is the large-scale study of proteins, particularly their expression, structures and functions. This still-emerging combination of technologies aims to describe and characterize all expressed proteins in a biological system. Because of upper limits on mass detection of mass spectrometers, proteins are usually digested into peptides and the peptides are then separated, identified and quantified from this complex enzymatic digest. The problem in digesting proteins first and then analyzing the peptide cleavage fragments by mass spectrometry is that huge numbers of peptides are generated that overwhelm direct mass spectral analyses. The objective in the liquid chromatography approach to proteomics is to fractionate peptide mixtures to enable and maximize identification and quantification of the component peptides by mass spectrometry. This review will focus on existing multidimensional liquid chromatographic (MDLC) platforms developed for proteomics and their application in combination with other techniques such as stable isotope labeling. We also provide some perspectives on likely future developments.

Indexed as

Chromatography, LiquidChromatography, Reverse-PhaseGlycopeptidesIsotope LabelingPeptidesPhosphopeptidesProteinsProteomicsGlycopeptidesPeptidesPhosphopeptidesProteins

Identifiers

PMID20363391
PMCPMC2852180

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.